Future Market Insights has announced the addition of the “Veterinary Vaccines Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025" report to their offering.
Valley Cottage, NY -- (SBWIRE) -- 05/12/2016 -- Veterinary vaccines help in improvinganimal health, increase production of livestock in a cost effective manner and preventtransmission of diseases among animals. The veterinary vaccines market has witnessed double digit growth over the past few years, due to fear of impending pandemicsthat have led to heavy losses particularly in poultry. Theglobal veterinaryvaccines market is driven by factors such as the vulnerability of animals to fatal and chronic diseases, and rapidly changing patterns of diseases among animals. Veterinary vaccines have also reduced the amount of drug treatments to control established diseases and, in many instances, have prevented long term suffering and death. The global veterinary vaccines market has undergone considerable progress during the past few years with the increasing use of continuous cell lines as a substrate and adoption of the fermentor technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics.
The global veterinary vaccines market has been segmented based on diseases, products and vaccine type. Product segment has been further divided into companion, livestock, poultry, porcine, equine, and aquaculture vaccines. Companion animal vaccines include vaccines for canine and feline purpose. Livestock vaccines include those for bovine use. These product types are further classified based on the diseasessome of which include canine rabies, infectious canine hepatitis, felineleukemia, bovine viral diarrhea, brucellosis, infectious bovine rhinotracheitis,pasteurellosis, furunculosis, strangles, equine influenza (Horse Flu) amongst others. Types of vaccines have been classified based on their manufacturing process using various technologies. These include live attenuated, inactivated, subunit, conjugate, toxoid, recombinant and DNA vaccines.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-409
Among the four major geographies namely North America, Europe, Asia-Pacific and Rest of the world, European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S. These two regions collectively account for more than 70% of the global veterinary vaccine market revenue. Growing demand for the vaccines from Asia, Latin America and Eastern European countries and increased vulnerability of animals to fatal and chronic diseases is steering the demand for veterinary vaccines.The manufacturers areinvesting heavily in new product developments due to rapidly changing patterns of the diseasesand increased resistance to the currently used vaccines. Growing awareness on animal health with early disease detection and preventive medicines will drive the demand for veterinary vaccines in the coming years. Technological advancements such as introduction of DNA vaccines and other productswill ensure greater production and immune responses than the conventional vaccines. Increased demand for animal protein, including milk, meat, eggs and fish, increased expenditure on healthcare of companion animals, are the major factors expected to boost the growth of the global veterinary vaccines market.
Increasingawareness against the use of antimicrobials is encouraging the vaccine producers to invest significantly into development of new products.Many of the established bacterial vaccines are highly efficacious. Certain vaccines such as live and inactivated bacterial vaccines are also produced by local veterinary institutions or specialized companies for on-farm specific demands where no commercial vaccines are available.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-409
Sanofi Animal Health, Bayer HealthCare AG, Bioniche Animal Health Canada, Inc., Biogenesis Bago SA, Heska Corporation, Boehringer Ingelheim GmbH, Indian Immunologicals Ltd. Novartis Animal Heath, Inc., Merck & Co. Inc, Zoetis,Bayer AG,and Protein Sciences Corporation are the leading players in the global veterinary vaccine market. Other players include Imugene Limited, Lohmann Animal Health, Merck & Co. Inc., Embrex Inc., Intervet/Schering-Plough Animal Health,Fort Dodge Animal Health, Pfizer, Inc. and Virbac Corporation.